Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/84481
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The urgent need for an effective biomarker for cytotoxic therapy-induced adverse effects |
Author: | Gibson, R. |
Citation: | Current Opinion in Supportive and Palliative Care, 2013; 7(2):153-154 |
Publisher: | Lippincott Williams & Wilkins |
Issue Date: | 2013 |
ISSN: | 1751-4258 1751-4266 |
Statement of Responsibility: | Rachel J. Gibson |
Keywords: | Intestinal Mucosa Humans Citrulline Leukocyte L1 Antigen Complex Antineoplastic Agents Breath Tests Radiotherapy Hematopoietic Stem Cell Transplantation Toxicity Tests Biomarkers |
Rights: | © 2013 Wolters Kluwer Health. Lippincott Williams & Wilkins |
DOI: | 10.1097/SPC.0b013e32835e7f73 |
Published version: | http://dx.doi.org/10.1097/spc.0b013e32835e7f73 |
Appears in Collections: | Aurora harvest 7 Public Health publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.